User profiles for "author:Hasan Yazici"

Hasan Yazıcı

Kocaeli Üniversitesi
Verified email at kocaeli.edu.tr
Cited by 33673

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

B Hellmich, O Flossmann, WL Gross, P Bacon… - Annals of the …, 2007 - ard.bmj.com
Objectives: To develop the European League Against Rheumatism (EULAR)
recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis …

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic …

C Mukhtyar, O Flossmann, B Hellmich… - Annals of the …, 2008 - ard.bmj.com
Objectives: We undertook a systematic literature review as a background to the European
League Against Rheumatism (EULAR) recommendations for conducting clinical trials in anti …

Behçet syndrome: a contemporary view

H Yazici, E Seyahi, G Hatemi, Y Yazici - Nature Reviews Rheumatology, 2018 - nature.com
The presence of symptom clusters, regional differences in disease expression and
similarities with, for example, Crohn's disease suggest multiple pathological pathways are …

EULAR recommendations for the management of primary small and medium vessel vasculitis

C Mukhtyar, L Guillevin, MC Cid, B Dasgupta… - Annals of the …, 2009 - ard.bmj.com
Objectives: To develop European League Against Rheumatism (EULAR) recommendations
for the management of small and medium vessel vasculitis. Methods: An expert group …

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including …

B Combe, R Landewé, C Lukas, HD Bolosiu… - Annals of the …, 2007 - ard.bmj.com
Objective: To formulate EULAR recommendations for the management of early arthritis.
Methods: In accordance with EULAR's “standardised operating procedures”, the task force …

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

E Kural-Seyahi, I Fresko, N Seyahi, Y Ozyazgan, C Mat… - Medicine, 2003 - journals.lww.com
We surveyed the 20-year outcome of a cohort of patients with Behçet syndrome with
emphasis on both mortality and morbidity. During 1999 and 2000, we collected outcome …

[HTML][HTML] A controlled trial of azathioprine in Behcet's syndrome

H Yazici, H Pazarli, CG Barnes, Y Tüzün… - … England Journal of …, 1990 - Mass Medical Soc
Cytotoxic agents have long been used in Behçet's syndrome, especially for eye involvement,
but their effectiveness has been uncertain. We conducted a two-year randomized, placebo …

EULAR recommendations for the management of large vessel vasculitis

C Mukhtyar, L Guillevin, MC Cid, B Dasgupta… - Annals of the …, 2009 - ard.bmj.com
Objectives: To develop European League Against Rheumatism (EULAR) recommendations
for the management of large vessel vasculitis. Methods: An expert group (10 …

2018 update of the EULAR recommendations for the management of Behçet's syndrome

G Hatemi, R Christensen, D Bang, B Bodaghi… - Annals of the …, 2018 - ard.bmj.com
Several new treatment modalities with different mechanisms of action have been studied in
patients with Behçet's syndrome (BS). The aim of the current effort was to update the …

Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome: a randomized, double-blind, placebo-controlled trial

V Hamuryudan, C Mat, S Saip, Y Ozyazgan… - Annals of internal …, 1998 - acpjournals.org
Background: Recurrent oral and genital ulcers are the most frequent problem in the
management of the Behcet syndrome. Uncontrolled experience suggests that thalidomide …